Chimin(SH:603222)2020-04-29 16:00Financial Performance - Operating revenue fell by 31.66% to CNY 131,807,335.11 year-on-year[5] - Net profit attributable to shareholders decreased by 219.32% to a loss of CNY 10,550,402.49[5] - Basic and diluted earnings per share both dropped by 150.00% to CNY -0.02[5] - Total operating revenue for Q1 2020 was ¥131,807,335.11, a decrease of 31.7% compared to ¥192,878,575.35 in Q1 2019[25] - Net profit for Q1 2020 was a loss of ¥11,528,058.65, compared to a profit of ¥13,596,802.12 in Q1 2019, indicating a significant decline[26] - The company reported a gross margin of approximately -10.4% in Q1 2020, down from a positive margin in Q1 2019[25] - Total operating costs decreased to ¥150,156,153.83 in Q1 2020 from ¥175,629,669.68 in Q1 2019, representing a reduction of 14.5%[25] - Total comprehensive income for Q1 2020 was a loss of ¥11,555,523.41, compared to a gain of ¥12,226,066.43 in Q1 2019[27] Cash Flow - Cash flow from operating activities showed a decline of 180.82%, resulting in a negative cash flow of CNY 4,667,291.75[5] - The cash inflow from operating activities was CNY 148,378,096.21, a decrease of 16.43% compared to CNY 177,575,194.25 in Q1 2019[33] - The net cash flow from operating activities was negative at CNY -4,667,291.75, contrasting with a positive CNY 5,775,207.01 in the same period last year[33] - The cash inflow from investment activities was CNY 24,533,333.00, while the cash outflow was CNY 48,310,785.36, resulting in a net cash flow from investment activities of CNY -23,777,452.36[34] - The cash inflow from financing activities was CNY 180,758,153.74, an increase of 16.19% from CNY 155,500,000.00 in Q1 2019[34] - The net cash flow from financing activities was CNY 31,118,095.68, down from CNY 78,712,587.66 in the previous year[34] - The total cash and cash equivalents at the end of Q1 2020 were CNY 141,845,494.93, a decrease from CNY 149,916,323.81 at the end of Q1 2019[34] Assets and Liabilities - Total assets decreased by 0.61% to CNY 2,071,718,178.25 compared to the end of the previous year[5] - Current liabilities increased from ¥655,015,544.37 to ¥709,174,430.19, an increase of about 8.3%[20] - Non-current liabilities decreased from ¥356,667,015.05 to ¥301,291,665.65, a reduction of approximately 15.5%[20] - Total liabilities remained relatively stable, decreasing slightly from ¥1,011,682,559.42 to ¥1,010,466,095.84[20] - Total equity decreased from ¥1,072,807,605.82 to ¥1,061,252,082.41, a decline of about 1.4%[21] - The company’s total current assets amounted to CNY 694,990,673.17 as of Q1 2020[38] - The company’s total non-current assets were valued at CNY 1,370,000,000.00, indicating a stable asset base[38] Shareholder Information - The number of shareholders reached 5,904 at the end of the reporting period[9] - The largest shareholder, Shuangge Group Co., Ltd., holds 36.20% of the shares, totaling 115,830,800 shares[9] Government Support and Subsidies - The company received government subsidies amounting to CNY 1,369,828.53 during the reporting period[8] Changes in Financial Reporting - The company is implementing new revenue and leasing standards effective from January 1, 2020, which may impact future financial reporting[44] - The company’s contract liabilities were adjusted from "prepayments" due to the implementation of new revenue recognition standards, resulting in a significant reclassification[12] Investment and Acquisitions - The company acquired 80% of Ezhou Second Hospital, with ongoing legal proceedings regarding performance compensation due to unmet profit commitments[13] - The company reported a significant increase in financial expenses, with interest expenses rising to ¥8,941,968.52 in Q1 2020 from ¥6,867,875.04 in Q1 2019[25] - The company’s investment income was CNY 2,435,959.08, primarily from interest income on receivable equity buybacks[12]